Atrial fibrillation and congestive heart failure: Risk factors, mechanisms, and treatment

Progress in Cardiovascular Diseases

Volumn 48, Issue 4, 2006, Pages 256-269

  Heist, E Kevin ^a   Ruskin, Jeremy N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTILIPEMIC AGENT; AZIMILIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOFETILIDE; FLECAINIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; POTASSIUM CHANNEL BLOCKING AGENT; PROPAFENONE; PROTEIN; PROTEIN SERCA2A; SODIUM CHANNEL BLOCKING AGENT; SOTALOL; UNCLASSIFIED DRUG; VERAPAMIL;

ADENOVIRUS VECTOR; AGE DISTRIBUTION; ARTIFICIAL HEART PACEMAKER; BIOLOGICAL THERAPY; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVERSION; CATHETER ABLATION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENETIC RISK; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HERITABILITY; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; TREATMENT OUTCOME; TREATMENT PLANNING; VALVULAR HEART DISEASE; VIRAL GENE THERAPY;

ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CATHETER ABLATION; COMORBIDITY; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; PACEMAKER, ARTIFICIAL; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33644654282     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2005.09.001     Document Type: Review

References (84)

1. R.L. McNamara, L.J. Tamariz, and J.B. Segal Management of atrial fibrillation: Review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography Ann. Intern. Med. 139 2003 1018 1033
2. D.M. Lloyd-Jones, T.J. Wang, and E.P. Leip Lifetime risk for development of atrial fibrillation: The Framingham Heart Study Circulation 110 2004 1042 1046
3. W.B. Kannel, R.D. Abbott, and D.D. Savage Epidemiologic features of chronic atrial fibrillation: The Framingham study N. Engl. J. Med. 306 1982 1018 1022
4. American Heart Association 2002 Heart and Stroke Statistical Update 2001 American Heart Association Dallas, TX
5. M. Jessup, and S. Brozena Heart failure N. Engl. J. Med. 348 2003 2007 2018
6. Y.M. Cha, M.M. Redfield, and W.K. Shen Atrial fibrillation and ventricular dysfunction: A vicious electromechanical cycle Circulation 109 2004 2839 2843
7. J. Mackenzie Diseases of the heart ed 3 1914 Oxford Medical Publications London, UK
8. P.D. White Heart disease 1937 The McMillan Co New York, NY
9. M. Pozzoli, G. Cioffi, and E. Traversi Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: A prospective study in 344 patients with baseline sinus rhythm J. Am. Coll. Cardiol. 32 1998 197 204
10. P.T. Ellinor, and C.A. Macrae The genetics of atrial fibrillation J. Cardiovasc. Electrophysiol. 14 2003 1007 1009
11. D. Darbar, K.J. Herron, and J.D. Ballew Familial atrial fibrillation is a genetically heterogeneous disorder J. Am. Coll. Cardiol. 41 2003 2185 2192
12. Y.H. Chen, S.J. Xu, and S. Bendahhou KCNQ1 gain-of-function mutation in familial atrial fibrillation Science 299 2003 251 254
13. H. Niimura, K.K. Patton, and W.J. McKenna Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly Circulation 105 2002 446 451
14. E.L. Burkett, and R.E. Hershberger Clinical and genetic issues in familial dilated cardiomyopathy J. Am. Coll. Cardiol. 45 2005 969 981
15. E.J. Benjamin, D. Levy, and S.M. Vaziri Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study JAMA 271 1994 840 844
16. T.J. Wang, H. Parise, and D. Levy Obesity and the risk of new-onset atrial fibrillation JAMA 292 2004 2471 2477
17. R.H. Falk Atrial fibrillation N. Engl. J. Med. 344 2001 1067 1078
18. A.S. Gami, G. Pressman, and S.M. Caples Association of atrial fibrillation and obstructive sleep apnea Circulation 110 2004 364 367
19. J.L. Anderson, C.A. Allen Maycock, and D.L. Lappé Frequency of elevation of C-reactive protein in atrial fibrillation Am. J. Cardiol. 94 2004 1255 1259
20. R. Marcucci, I. Betti, and E. Cecchi Hyperhomocysteinemia and vitamin B6 deficiency: New risk markers for nonvalvular atrial fibrillation? Am. Heart J. 148 2004 456 461
21. L.H. Lund, and D. Mancini Heart failure in women Med. Clin. North. Am. 88 2004 1321 1345
22. R.T. Tsuyuki, R.S. McKelvie, and J.M. Arnold Acute precipitants of congestive heart failure exacerbations Arch. Intern. Med. 161 2001 2337 2342
23. P.M. Diller, D.R. Smucker, and B. David Congestive heart failure due to diastolic or systolic dysfunction. Frequency and patient characteristics in an ambulatory setting Arch. Fam. Med. 8 1999 414 420
24. G.P. Aurigemma, and W.H. Gaasch Clinical practice. Diastolic heart failure N. Engl. J. Med. 351 2004 1097 1105
25. T.J. Wang, M.G. Larson, and D. Levy Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study Circulation 107 2003 2920 2925
26. S.M. Vaziri, M.G. Larson, and E.J. Benjamin Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study Circulation 89 1994 724 730
27. M.O. Sweeney, A.S. Hellkamp, and K.A. Ellenbogen Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction Circulation 107 2003 2932 2937
28. D.L. Dries, D.V. Exner, and B.J. Gersh Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction J. Am. Coll. Cardiol. 32 1998 695 703
29. W.S. Aronow, C. Ahn, and I. Kronzon Prognosis of congestive heart failure after prior myocardial infarction in older persons with atrial fibrillation versus sinus rhythm Am. J. Cardiol. 87 2001 224 225
30. P. Mahoney, S. Kimmel, and D. DeNofrio Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure Am. J. Cardiol. 83 1999 1544 1547
31. J.R. Ehrlich, S. Nattel, and S.H. Hohnloser Atrial fibrillation and congestive heart failure: Specific considerations at the intersection of two common and important cardiac disease sets J. Cardiovasc. Electrophysiol. 13 2002 399 405
32. D. Li, S. Fareh, and T.K. Leung Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort Circulation 100 1999 87 95
33. F. Ravelli, and M. Allessie Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart Circulation 96 1997 1686 1695
34. K. Shinagawa, D. Li, and T.K. Leung Consequences of atrial tachycardia-induced remodeling depend on the preexisting atrial substrate Circulation 105 2002 251 257
35. L. Yue, J. Feng, and R. Gaspo Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation Circ. Res. 81 1997 512 525
36. D. Li, P. Melnyk, and J. Feng Effects of experimental heart failure on atrial cellular and ionic electrophysiology Circulation 101 2000 2631 2638
37. L. Yue, P. Melnyk, and R. Gaspo Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation Circ. Res. 84 1999 776 784
38. T.J. Cha, J.R. Ehrlich, and L. Zhang Atrial ionic remodeling induced by atrial tachycardia in the presence of congestive heart failure Circulation 110 2004 1520 1526
39. F. Bode, A. Katchman, and R.L. Woosley Gadolinium decreases stretch-induced vulnerability to atrial fibrillation Circulation 101 2000 2200 2205
40. 2+ regulatory proteins in the atrial tissue of patients with chronic atrial fibrillation J. Am. Coll. Cardiol. 34 1999 255 263
41. D.J. Beuckelmann, M. Näbauer, and E. Erdmann Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure Circulation 85 1992 1046 1055
42. K.T. Weber, C.G. Brilla, and J.S. Janicki Myocardial fibrosis: Functional significance and regulatory factors Cardiovasc. Res. 27 1993 341 348
43. D. Li, K. Shinagawa, and L. Pang Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure Circulation 104 2001 2608 2614
44. S. Cardin, D. Li, and N. Thorin-Trescases Evolution of the atrial fibrillation substrate in experimental congestive heart failure: Angiotensin-dependent and -independent pathways Cardiovasc. Res. 60 2003 315 325
45. K. Shinagawa, Y.F. Shi, and J.C. Tardif Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs Circulation 105 2002 2672 2678
46. T.J. Cha, J.R. Ehrlich, and L. Zhang Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure Circulation 109 2004 412 418
47. M. Grogan, H.C. Smith, and B.J. Gersh Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy Am. J. Cardiol. 69 1992 1570 1573
48. D.G. Wyse, A.L. Waldo, and J.P. DiMarco A comparison of rate control and rhythm control in patients with atrial fibrillation N. Engl. J. Med. 347 2002 1825 1833
49. I.C. Van Gelder, V.E. Hagens, and H.A. Bosker A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N. Engl. J. Med. 347 2002 1834 1840
50. A.B. Curtis, B.J. Gersh, and S.D. Corley Clinical factors that influence response to treatment strategies in atrial fibrillation: The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Am. Heart J. 149 2005 645 649
51. S.M. Al-Khatib, L.K. Shaw, and K.L. Lee Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure? Am. J. Cardiol. 94 2004 797 800
52. J.L. Blackshear, and R.E. Safford AFFIRM and RACE trials: Implications for the management of atrial fibrillation Card. Electrophysiol. Rev. 7 2003 366 369
53. S.D. Corley, A.E. Epstein, and J.P. DiMarco Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study Circulation 109 2004 1509 1513
54. B.N. Singh, S.N. Singh, and D.J. Reda Amiodarone versus sotalol for atrial fibrillation N. Engl. J. Med. 352 2005 1861 1872
55. J.A. Joglar, A.P. Acusta, and N.H. Shusterman Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: Retrospective analysis of the US Carvedilol Heart Failure Trials Program Am. Heart. J. 142 2001 498 501
56. I.A. Khan, C.K. Nair, and N. Singh Acute ventricular rate control in atrial fibrillation and atrial flutter Int. J. Cardiol. 97 2004 7 13
57. D.S. Echt, P.R. Liebson, and L.B. Mitchell Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial N. Engl. J. Med. 324 1991 781 788
58. S.S. Gottlieb, M.L. Kukin, and N. Medina Comparative hemodynamic effects of procainamide, tocainide, and encainide in severe chronic heart failure Circulation 81 1990 860 864
59. A. Hallstrom, C.M. Pratt, and H.L. Greene Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: Analysis of the Cardiac Arrhythmia Suppression Trial J. Am. Coll. Cardiol. 25 1995 1250 1257
60. D. Roy, M. Talajic, and P. Dorian Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators N. Engl. J. Med. 342 2000 913 920
61. O.D. Pedersen, H. Bagger, and N. Keller Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: A Danish investigations of arrhythmia and mortality on dofetilide (DIAMOND) substudy Circulation 104 2001 292 296
62. C.M. Pratt, S.N. Singh, and H.R. Al-Khalidi The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: Results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial J. Am. Coll. Cardiol. 43 2004 1211 1216
63. O.D. Pedersen, H. Bagger, and L. Kober Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction Circulation 100 1999 376 380
64. A.H. Madrid, M.G. Bueno, and J.M. Rebollo Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: A prospective and randomized study Circulation 106 2002 331 336
65. Y. Young-Xu, S. Jabbour, and R. Goldberg Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease Am. J. Cardiol. 92 2003 1379 1383
66. E.G. Daoud, C. Timmermans, and C. Fellows Initial clinical experience with ambulatory use of an implantable atrial defibrillator for conversion of atrial fibrillation. Metrix Investigators Circulation 102 2000 1407 1413
67. G.R. D'Allonnes, D. Pavin, and C. Leclercq Long-term effects of biatrial synchronous pacing to prevent drug-refractory atrial tachyarrhythmia: A nine-year experience J. Cardiovasc. Electrophysiol. 11 2000 1081 1091
68. J.G. Cleland, J.C. Daubert, and E. Erdmann The effect of cardiac resynchronization on morbidity and mortality in heart failure N. Engl. J. Med. 352 2005 1539 1549
69. S.G. Molhoek, J.J. Bax, and G.B. Bleeker Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation Am. J. Cardiol. 94 2004 1506 1509
70. J.W.H. Fung, C.M. Yu, and J.Y.S. Chan Effects of cardiac resynchronization therapy on incidence of atrial fibrillation in patients with poor left ventricular systolic function Am. J. Cardiol. 96 2005 728 731
71. M.M. Scheinman, F. Morady, and D.S. Hess Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias JAMA 248 1982 851 855
72. V. Valls-Bertault, M. Fatemi, and M. Gilard Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation Europace 6 2004 438 443
73. G.K. Moe Evidence for reentry as a mechanism of cardiac arrhythmias Rev. Physiol. Biochem. Pharmacol. 72 1975 55 81
74. G.G. de Lima, R.A. Kalil, and T.L. Leiria Randomized study of surgery for patients with permanent atrial fibrillation as a result of mitral valve disease Ann. Thorac. Surg. 77 2004 2089 2094 (discussion 2094-5)
75. T. Nitta Surgery for atrial fibrillation Ann. Thorac. Cardiovasc. Surg. 11 2005 154 158
76. M. Haïssaguerre, P. Jaïs, and D.C. Shah Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins N. Engl. J. Med. 339 1998 659 666
77. M. Mansour, J. Ruskin, and D. Keane Efficacy and safety of segmental ostial versus circumferential extra-ostial pulmonary vein isolation for atrial fibrillation J. Cardiovasc. Electrophysiol. 15 2004 532 537
78. C. Pappone, S. Rosanio, and G. Oreto Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation Circulation 102 2000 2619 2628
79. H. Oral, C. Scharf, and A. Chugh Catheter ablation for paroxysmal atrial fibrillation: Segmental pulmonary vein ostial ablation versus left atrial ablation Circulation 108 2003 2355 2360
80. B.J. Mikaelian, Z.J. Malchano, and P. Neuzil Images in cardiovascular medicine. Integration of 3-dimensional cardiac computed tomography images with real-time electroanatomic mapping to guide catheter ablation of atrial fibrillation Circulation 112 2005 e35 e36
81. L.F. Hsu, P. Jaïs, and P. Sanders Catheter ablation for atrial fibrillation in congestive heart failure N. Engl. J. Med. 351 2004 2373 2383
82. K.C. Wollert, and H. Drexler Clinical applications of stem cells for the heart Circ. Res. 96 2005 151 163
83. J.K. Donahue, A.W. Heldman, and H. Fraser Focal modification of electrical conduction in the heart by viral gene transfer Nat. Med. 6 2000 1395 1398
84. F. del Monte, S.E. Harding, and U. Schmidt Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a Circulation 100 1999 2308 2311